Diving into HCA and Tenet's Q1s with some visual analysis
{beacon}
PARTNERED WITH
{if hosp_dorm_120 == true}
Quick favor: Our records indicate that you aren’t opening this email. But records can be wrong. Please click here if you’d like to remain subscribed to Hospitalogy.
{/if}
Happy Thursday, Hospitalogists!
I love you all.
With that out of the way, today is day 1 of the new Thursday format. Let me know what you guys think! There will probably be a few more tweaks to colors, etc.
As a reminder, the new format for Hospitalogy is as follows:
Tuesdays:
1-3 biggest healthcare headlines from the week; associated commentary
Strategy Spotlight (breakdowns of developing trends to keep a pulse on)
Partnerships Pulse (link roundup of important partnerships & collaborations)
In case you missed it, I've revamped my community with a lower price point and a ton of exclusive new features.
My whole goal with the community is to join, network with people across healthcare, and break the siloes to understand the big picture of what's actually going on in our industry.
For strategy, finance, and intellectually curious folks, I'd love for you to check it out! (note: community is not gated to executives). Scholarships available.
A deeper dive into an ongoing healthcare issue or story
HCA, Tenet off to Strong 2024
We’re all seeing the headlines emerging from UnitedHealth, Humana, and CVS (particularly Humana and, CVS - which posted one of the biggest stock declines in its company history, sheesh) around MA struggles along with commentary around utilization stabilizing at current levels:
“What we've seen in orthopedic, cardiac, those kind of categories primarily have been the big factors…So the percentage growth in those was much bigger last year. You're coming off an environment where both the supply side had been constrained and the willingness of seniors, in particular, consumers to access that environment had been constrained for a couple of years. So those percentage factors were quite significant.
You heard us talk about very significant levels on those double-digit levels of last year as we looked at those. The way we look at those really, though, is because you would expect that to start normalizing in terms of the percentage change.” UnitedHealth Group Q1 2024 earnings call
Naturally, the other side of that utilization equation means health systems and organizations positioned to capture volumes and continue their recovery…will do so. So, HCA and Tenet are two obvious outsized beneficiaries and we saw that effect play out on Q1 results.
Tenet in particular way outperformed expectations in Q1 and is excited about the current operating environment with rising volumes.
Interestingly, while HCA outperformed financially, the hospital giant DID see a small decline in outpatient surgeries. Management attributed that trend to lost volumes from self-pay and Medicaid redeterminations along with some calendar dynamics with Easter falling in Q1, so it's probably nothing noteworthy. But I do think the outpatient book of business is a key area to watch moving forward given intensity of competition in the outpatient setting.
Moving forward, from Q2 onward, we should see growth (in percentage terms) taper off, given elevated utilization trends started in Q2 of 2023. That dynamic is reflected in UnitedHealth Group’s commentary above.
“USPI's first quarter adjusted EBITDA grew 16% compared to last year, and its adjusted EBITDA margin continues to be very strong at 39.6%. USPI delivered a 6.4% increase in same-facility system-wide revenues compared to first quarter of 2023, with same-facility system-wide net revenue per case, up 6.8%, driven by high levels of acuity.
This was partially offset by a modest decrease in surgical case volume of 0.4%, in line with our expectations. As we noted last quarter, we are expecting growth in cases to build over the year, due to the significant volume performance we saw in the first quarter of 2023.” - Tenet Healthcare Q1 2024 earnings call.
Here’s an extra comparative table, just because I like you guys (the Tenet number is conflated with all the $ coming in from divestitures - take a look at adjusted EBITDA figure for more comparative figures):
From a broader hospital perspective, financial recovery post-pandemic continues to see a positive trend despite a recent dip in March, per Kaufman Hall’s latest hospital flash report:
BUT this health system recovery is not homogenous - it's lumpy. The ones who are ahead...are staying ahead. The bottom quartile or so of hospitals are doing increasingly worse, leading to a mixed bag of conversations when it comes to hospital finances. Gist Healthcare had a nice graphic on this dynamic. Will we see this trend alleviate given above tailwinds? Something to keep in mind.
2. What's Trending this week?
Social discourse and conversations from around healthcare
Dan Diamond’s thread on UnitedHealth Group’s CEO Andrew Witty testifying related to the Change Healthcare hack and antitrust. Can you believe Change Healthcare didn’t have multi-factor authentication set up?
Aledade’s Farzad Mostashari’s tweet storm on Walmart Health and primary care spurred some interesting dialogue.
3. Community Update
The latest from inside my community
Yesterday, I released the first official Hospitalogy quarterly industry update, hitting on major themes and strategies for payors, health systems, and more including all the big headlines and stories from Q1.
It’s a ~30 or so page report sent to Hospitalogy community members, and given the amount of hours I put into it, probably worth the cost of annual membership by itself (but then of course, beauty is in the eye of the beholder)!
You can get it ASAP by signing up for the community here, which gets you access to reports like these along with networking opportunities, monthly masterminds, and fireside conversations with interesting professionals across healthcare.
Struggling with the efficiency of post-discharge visits?
You're not alone—we're seeing this play out across the entire industry.
The introduction of Medicare’s Transitional Care Management (TCM) program has put a spotlight on the need for streamlined post-discharge processes, and WellSky’s platform is here to help!
It fits right into your existing workflow, simplifying the TCM process by automating the tracking and management of patient visits.
With WellSky, providers have captured 49% more encounters, built over 44% more revenue, and reduced readmissions by nearly 3%.
Boost your post-discharge efficiency with WellSky and see the difference it can make in your patient outcomes.